Actidose Suspension
NDC 0574-0520

View dosage, usage, ingredients, routes, and UNII mappings.
Table of Contents
  1. Product Information
  2. Product Packages
  3. What is NDC 0574-0520?
  4. Actidose Uses
  5. Active Ingredients
  6. Active Ingredients UNII Codes
  7. Inactive Ingredients UNII Codes
  8. NDC to RxNorm Crosswalk
  9. Patient Education

Product Information

Actidose (activated charcoal) is a OTC MONOGRAPH DRUG-approved product labeled by Padagis Us Llc. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a suspension for oral administration. This product entry covers the primary NDC 0574-0520 and 4 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.

Primary Identification

NDC Product Code:
0574-0520
Proprietary Name:
Actidose
Non-Proprietary Name: [1]
Activated Charcoal
Substance Name: [2]
Activated Charcoal
NDC Directory Status:
Human Otc Drug
Product Type: [3]
ACTIVE PRODUCT INCLUDED in the NDC Directory
Code Navigator:

Clinical Specifications

Dosage Form:
Suspension - A liquid1 dosage form that contains solid particles dispersed in a liquid vehicle.
Administration Route(s): [4]
Oral - Administration to or by way of the mouth.

Labeler & Regulatory Data

Labeler Name: [5]
Padagis Us Llc
Labeler Code:
0574
Product Label ID:
76e4fe6a-afd4-4f68-b12d-0b094f750615
FDA Application Number: [6]
M023
Marketing Category: [8]
OTC MONOGRAPH DRUG

Marketing Timeline

Start Marketing Date: [9]
12-05-2020
Listing Expiration Date: [11]
12-31-2027
Exclude Flag: [12]
N

Code Structure Chart

Product Details

What is NDC 0574-0520?

The NDC code 0574-0520 is assigned by the FDA to the product Actidose. It is commonly known by its generic name, activated charcoal. This pharmaceutical product is labeled by Padagis Us Llc and is currently categorized as listed product. The medication is a suspension administered via oral route. In terms of distribution, this product is available in 4 different package configurations. The associated package NDC(s) include: 0574-0520-04, 0574-0520-08, 0574-0520-74, 0574-0520-76. Beyond standard identification, this entry provides technical data including pharmacologic classes, UNII ingredient references, and RxNorm cross-referencing for healthcare systems.

What are the uses of this product?

•Shake well. •Unscrew cap and remove foil seal. Replace cap to administer. •If delivering entire container to patient, rinse container with water and give residue to patient to ensure entire dose has been delivered. Under 1 year1 – 12 yearsAdults (over 12 years)Single DoseDo not use25 – 50 g (120 – 240 mL) do not use 25 g in child weighing less than 16 kg (35 pounds) do not use 50 g in child weighing less than 32 kg (70 pounds)50 g (240 mL)Multiple DoseNot recommended for children or adults•If previous attempts to contact a poison control center, emergency medical facility, or health professional were unsuccessful, continue trying. Keep patient active and moving. Save the container of poison.

What are Active Ingredients of this product?

An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

Which are the associated UNII Codes?

The UNII codes for the active ingredients in this product are:

Which are the Inactive Ingredients associated UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

What is the NDC to RxNorm Crosswalk for this product?

RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:

* Please review the full disclaimer at the bottom of this page.

Patient Education

Activated Charcoal


What is it? Activated charcoal has pores that can trap chemicals. It is typically taken by mouth as a treatment for some swallowed poisons. There is little evidence for other uses.

Charcoal is made from peat, coal, wood, coconut shell, or petroleum. Activated charcoal is made by heating charcoal in the presence of a gas. This process causes the charcoal to develop lots of internal spaces or pores. These pores help activated charcoal trap chemicals.

Activated charcoal is commonly used to treat poisoning. It is also used for high cholesterol, hangovers, and upset stomach, but there is no strong scientific evidence to support most of these uses.
[Learn More]


* Please review the full disclaimer at the bottom of this page.

Product & Regulatory Definitions
What is the Non-Proprietary Name? The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
What is the Substance Name? An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
What kind of product is this? Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
What are the Administration Routes? The translation of the route code submitted by the firm, indicating route of administration.
What is the Labeler Name? Name of Company corresponding to the labeler code segment of the Product NDC.
What is the FDA Application Number? This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
What is the Marketing Category? Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
What is the Start Marketing Date? This is the date that the labeler indicates was the start of its marketing of the drug product.
What is the Listing Expiration Date? This is the date when the listing record will expire if not updated or certified by the product labeler.
What is the NDC Exclude Flag? This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions, or because the listing certification is expired, or because the listing data was inactivated by FDA, or because it was discontinued by the labeler. Possible values in this field are: "D", "E", "I", "N", "U".